Turn energy production, grid infrastructure, and power consumption data into focused market strategies.
The demand for energy is on rise, and will continue scaling higher pushed by industrialization and urbanization. Currently, fossil fuels meet the major part of energy demand emanating from across the globe. However, environmental pollutions and concerns pertaining to depleting natural resources have swayed trends in favor of greener alternatives. Government support and rising investment towards energy-efficient resources by public as well as private sector have further steered the paradigm shift. The energy and power industry is expected to gain considerably from the ongoing transition, exhibiting impressive growth worldwide. The energy and power industry is also a highly regulated one, wherein regulatory uncertainties frequently obstruct the smooth sail of companies. It is currently undergoing rapid transformation, with governments adopting initiatives to curb dependence on non-renewable and traditional sources of energy. This in turn paves way for growth in the coming years, however, not without hindrances. Besides this, there are concerns pertaining to volatility of energy prices, depleting sources of non-renewable energy, and need to keep pace with robust advancements. Post-digitization, several companies have also come under cyber-threat. At Fortune Business Insights we work closely with companies to help them identify opportunities amidst a sea of change. We intend to resolve critical needs of organizations operating in the energy and power sector thus helping them establish a stronghold in the industry
The global cellulosic ethanol market size is projected to grow from $2.38 billion in 2026 to $10.09 billion by 2034, with a CAGR of 19.78%... Read More
The global high voltage gas insulated switchgear market size is projected to grow from $6.94 billion in 2026 to $10.34 billion by 2034... Read More
The global second-generation biofuel market size is projected to grow from $21.29 billion in 2026 to $43.00 billion by 2034, at a CAGR of 9.19%... Read More
The global sustainable transportation fuel market size is projected to grow from $225.02 billion in 2026 to $396.45 billion by 2034... Read More
The India E85-compatible fuel additives market size is projected to grow from $45.54 million in 2026 to $178.63 million by 2034... Read More
The India high-ethanol blend fuels (E25-E100) market size is projected to grow from $6.11 million in 2026 to $1,021.12 million by 2034... Read More
The global high voltage cables market size is projected to grow from $37.80 billion in 2025 to $65.88 billion by 2034, exhibiting a CAGR of 6.52%... Read More
The global perovskite solar cells market size is projected to grow from $101.02 million in 2025 to $3,221.11 million by 2034, at CAGR of 48.38%... Read More
The biofuel storage and distribution market size is projected to grow from $14.93 billion in 2026 to $27.04 billion by 2034, over a CAGR of 7.71%... Read More
The India sustainable transportation fuels market size is projected to grow from $10.41 billion in 2026 to $22.65 billion by 2034, exhibiting a CAGR of 10.21%... Read More
The global transmission substation market size is projected to grow from $93.03 billion in 2026 to $165.99 billion by 2034, at a CAGR of 7.51%... Read More
The global hydrogen blending in natural gas market size is projected to grow from $14.39 billion in 2026 to $45.84 billion by 2034... Read More
The global wire and cable market size is projected to grow from $246.48 billion in 2026 to $410.70 billion by 2034, exhibiting a CAGR of 6.59%... Read More
The hydrogen fueling station market size is projected to grow from $1,192.67 million in 2026 to $6,592.68 million by 2034, exhibiting a CAGR of 23.83%... Read More
The global portable energy storage market size is projected to grow from $6.40 billion in 2026 to $32.07 billion by 2034, exhibiting a CAGR of 22.34%... Read More
The transportation biofuels market size is projected to grow from $155.70 billion in 2026 to $313.28 billion by 2034, exhibiting a CAGR of 9.13%... Read More
The India ethanol fuel dispensing infrastructure market size is projected to grow from $1,084.58 Mn in 2026 to $3,256.70 Mn by 2034, at a CAGR of 14.73%... Read More
The global hybrid solar wind system market size is projected to grow from $1.56 billion in 2026 to $5.32 billion by 2034, exhibiting a CAGR of 16.58%... Read More
The global advanced biofuels market size is projected to grow from $20.90 billion in 2026 to $45.69 billion by 2034, at CAGR of 10.27% over the forecast period... Read More
The global drilling automation market size is projected to grow from $3.33 billion in 2026 to $6.30 billion by 2034, at a CAGR of 8.3% during the forecast period... Read More
industries.healthcare.healthcare_infrastructure.description
The primary objective of epidemiology reports is to provide data-driven insights into the incidence, prevalence, and distribution of diseases across different populations, geographies and time periods. These reports can play a crucial role in the assessment of market potential based on patient populations and drive the strategies for the development for healthcare products such as pharmaceuticals, medical devices, or diagnostics. Epidemiology reports include segmentation by age, gender, region, and disease stage, enabling companies to make informed decisions about market entry, product positioning, and clinical trial planning.
Assist in the estimation of the potential/addressable market based on patient population
Provide an understanding of the trend in patient population
Provide an overview of the cost of care & therapeutics market
Provide an understanding of the disease landscape
Provide an understanding of the treated patient population
We can check the feasibility of adding specific countries to the geographic scope based on your requirements.
USA
UK
Germany
France
Italy
Spain
Japan
China
India
AustraliaGlobally, chronic diseases account for almost three-quarters of all deaths. At present, more than one in three adults have at least one chronic condition. Unhealthy lifestyle and ageing population are some of the main factors contributing to the growing burden of non-communicable diseases such as diabetes and cardiovascular conditions.
Management of chronic diseases and treatment of conditions due to these chronic diseases accounts for a significantly large proportion of the total healthcare spending of all countries, developed as well as
In the U.S., around 90% of the annual healthcare spending is on people suffering from chronic and mental conditions.
The World Economic Forum estimates that the global cost of treating chronic diseases will be around USD 30 trillion by 2030.
| DISEASE INDICATION |
U.S | U.K | Germany | France | Italy | Spain | Saudi Arabia | United Arab Emirates |
|---|---|---|---|---|---|---|---|---|
| Diabetes | 32.5 | 4.0 | 6.2 | 4.0 | 4.5 | 5.2 | 4.4 | 1.0 |
| Hypertension | 148.2 | 23.2 | 30.7 | 22.2 | 25.3 | 15.7 | 15.2 | 5.3 |
| Kidney Stone | 0.67 | 0.30 | 0.38 | 0.29 | 0.26 | 0.27 | 0.13 | 0.03 |
| Obesity | 109.3 | 23.6 | 21.3 | 13.6 | 10.4 | 10.3 | 10.1 | 3.9 |
Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. If it is not treated, cancer can invade surrounding tissues and spread to other parts of the body.
Around 20 million new cancer cases are diagnosed every year with men accounting for roughly 51% of them. China, India, USA and Japan account for around 4% of new cancer cases globally.
| Type | Cancer Incidence |
|---|---|
| Trachea, Bronchus & Lung | 2.5 |
| Breast | 2.3 |
| Colorectum | 1.9 |
| Prostate | 1.5 |
| Stomach | 0.97 |
| Liver | 0.87 |
| Thyroid | 0.82 |
| Cervix Uteri | 0.66 |
| Bladder | 0.61 |
| Non-Hodgkin Lymphoma | 0.55 |
Lung Cancer, Breast Cancer, Colorectal Cancer and Prostate Cancer account for around 44% of the new cancer cases (excluding non-melanoma skin cancer).
Diabetes is a chronic medical condition in which the body either doesn't produce enough insulin or can't effectively use the insulin it produces, leading to elevated levels of glucose in the blood. Over time, high blood sugar can cause serious damage to the heart, kidneys, eyes, and nerves.
Around 540 million people suffer from diabetes globally with more than 40% of the cases undiagnosed.
The two main types of diabetes are Type 1 and Type2. Type 1 is an autoimmune condition where the body destroys insulin-producing cells, requiring lifelong insulin therapy whereas Type 2 is a metabolic disorder where the body either doesn't produce enough insulin or cells become resistant to its effects. Type 2 accounts for around 96% of the prevalent diabetes cases.
Type 1
12,504,087 (4.4%)Type 2
269,376,970 (95.6%)0–19 yrs
579,27620–44 yrs
46,553,35345–64 yrs
91,116,784>64 yrs
143,631,644Men
146,030,908 (51.8%)Women
135,850,149 (48.2%)Conditions that impair the function of the kidneys, which are responsible for filtering waste and excess fluids from the blood, are known as kidney diseases. These diseases can range from acute kidney injury to chronic kidney disease (CKD), which may progress to kidney failure if not managed properly. Common causes include diabetes, high blood pressure, infections, and genetic disorders.
Globally, around 700 million people are estimated to be suffering from chronic kidney disease (CKD). Around 14% of adults in the U.S. are estimated to have CKD. Kidney diseases account for almost 2-4% of the total healthcare budgets in many developed nations. In the U.S., the annual cost of kidney diseases is estimated to be more than USD 85 billion.
Around 2 million people worldwide suffer from end-stage renal disease (ESRD), for which they receive dialysis or kidney transplants.
|
USA
|
750,000 |
|
Japan
|
350,000 |
|
Brazil
|
200,000 |
|
Germany
|
80,000 |
|
UK
|
70,000 |
A condition affecting less than 65 per 100,000 people is defined as a rare disease by the WHO. The global prevalence of more than 7,000 rare diseases together is around 300 million. More than 65% of the patients suffering from rare diseases are children and majority of these diseases do not have any treatment.
| Cystic Fibrosis | Lou Gehrig's Disease (ALS) | Huntington's Disease | Duchenne Muscular Dystrophy (DMD) |
|---|---|---|---|
| 40,000 | 18,000 | 30,000 | 15,000 |
Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including conditions like coronary artery disease, heart failure, stroke, and hypertension. They are the leading cause of death globally, often resulting from a combination of lifestyle factors and underlying health conditions.
It is estimated that around 60% of the U.S. adults will have some form of cardiovascular disease (CVD) in the next 30 years and the cost (direct and indirect) of CVD will be around USD 1.8 trillion. Globally, around 700 million people are living with CVDs and CVDs account for around one in three deaths every year.
Download Sample
Buy Now